Related Experiment Videos

Normal coronary angiograms: financial victory from the brink of clinical defeat?

B Keavney1, Y M Haider, A J McCance

  • 1Department of Cardiology, Glenfield General Hospital, Leicester, United Kingdom.

Insights

Patients with suspected ischemic heart disease who have normal coronary angiography results show a significant decrease in healthcare resource consumption afterward. Early investigation is safe and cost-effective in the medium term.

Area of Science:

  • Cardiology
  • Health Economics

Background:

  • Patients with suspected ischemic heart disease often undergo coronary angiography.
  • Normal angiographic results in these patients can lead to continued high healthcare resource consumption.

Purpose of the Study:

  • To test if normal coronary angiography results correlate with reduced healthcare resource use.
  • To evaluate the economic impact of early investigation for suspected coronary atherosclerosis.

Main Methods:

  • A retrospective cost-benefit analysis was conducted.
  • Compared 12-month periods before and after coronary angiography in 69 patients with normal results.
  • Assessed drug costs, hospital admissions, and general practitioner consultations.

Main Results:

  • Mean annual healthcare cost per patient before angiography was £656.89.
  • A significant reduction in resource consumption was observed post-angiography.
  • Mean monthly cost reduction was £35.15, with angiography costs recouped in 18 months.

Conclusions:

  • Patients with normal coronary arteries after angiography are significant healthcare consumers.
  • Early coronary angiography for suspected coronary atherosclerosis is safe.
  • Investigation yields beneficial medium-term resource consequences.
Abstract

Related Concept Videos